Literature DB >> 27793846

Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF.

Su Yeon Han1, Aram Ko1, Haruhisa Kitano2,3, Chel Hun Choi2,4, Min-Sik Lee1, Jinho Seo1, Junya Fukuoka5, Soo-Youl Kim6, Stephen M Hewitt2, Joon-Yong Chung2, Jaewhan Song7.   

Abstract

The tumor suppressor function of p14ARF is regulated at a posttranslational level via mechanisms yet to be fully understood. Here, we report the identification of an unconventional p14ARF degradation pathway induced by the chaperone HSP90 in association with the E3 ubiquitin ligase C-terminus of HSP70-interacting protein (CHIP). The ternary complex of HSP90, CHIP, and p14ARF was required to induce the lysosomal degradation of p14ARF by an ubiquitination-independent but LAMP2A-dependent mechanism. Depletion of HSP90 or CHIP induced p14ARF-dependent senescence in human fibroblasts. Premature senescence observed in cells genetically deficient in CHIP was rescued in cells that were doubly deficient in CHIP and p14ARF. Notably, non-small cell lung cancer cells (NSCLC) positive for p14ARF were sensitive to treatment with the HSP90 inhibitor geldanamycin. Furthermore, overexpression of HSP90 and CHIP with a concomitant loss of p14ARF correlated with poor prognosis in patients with NSCLC. Our findings identify a relationship between p14ARF and its chaperones that suggest new therapeutic strategies in cancers that overexpress HSP90. Cancer Res; 77(2); 343-54. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27793846      PMCID: PMC8170830          DOI: 10.1158/0008-5472.CAN-16-0613

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome.

Authors:  W G An; T W Schulte; L M Neckers
Journal:  Cell Growth Differ       Date:  2000-07

2.  Plasticity of the Hsp90 chaperone machine in divergent eukaryotic organisms.

Authors:  Jill L Johnson; Celeste Brown
Journal:  Cell Stress Chaperones       Date:  2008-07-18       Impact factor: 3.667

Review 3.  HSP90 and the chaperoning of cancer.

Authors:  Luke Whitesell; Susan L Lindquist
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

4.  Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.

Authors:  Delin Chen; Jing Shan; Wei-Guo Zhu; Jun Qin; Wei Gu
Journal:  Nature       Date:  2010-03-07       Impact factor: 49.962

5.  Non-small cell lung cancer, version 2.2013.

Authors:  David S Ettinger; Wallace Akerley; Hossein Borghaei; Andrew C Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Ramaswamy Govindan; Frederic W Grannis; Stefan C Grant; Leora Horn; Thierry M Jahan; Ritsuko Komaki; Feng-Ming Spring Kong; Mark G Kris; Lee M Krug; Rudy P Lackner; Inga T Lennes; Billy W Loo; Renato Martins; Gregory A Otterson; Jyoti D Patel; Mary C Pinder-Schenck; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; Theresa A Shapiro; Scott J Swanson; Kurt Tauer; Douglas E Wood; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2013-06-01       Impact factor: 11.908

6.  Post-translational disruption of the delta F508 cystic fibrosis transmembrane conductance regulator (CFTR)-molecular chaperone complex with geldanamycin stabilizes delta F508 CFTR in the rabbit reticulocyte lysate.

Authors:  W Fuller; A W Cuthbert
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

7.  Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2.

Authors:  Andrea D Basso; David B Solit; Pamela N Munster; Neal Rosen
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

8.  Nanog signaling in cancer promotes stem-like phenotype and immune evasion.

Authors:  Kyung Hee Noh; Bo Wook Kim; Kwon-Ho Song; Hanbyoul Cho; Young-Ho Lee; Jin Hee Kim; Joon-Yong Chung; Jae-Hoon Kim; Stephen M Hewitt; Seung-Yong Seong; Chih-Ping Mao; T-C Wu; Tae Woo Kim
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

9.  FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases.

Authors:  Qing Yao; Ritsuo Nishiuchi; Quanzhi Li; Ashish R Kumar; Wendy A Hudson; John H Kersey
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

Review 10.  Non-small-cell lung cancers: a heterogeneous set of diseases.

Authors:  Zhao Chen; Christine M Fillmore; Peter S Hammerman; Carla F Kim; Kwok-Kin Wong
Journal:  Nat Rev Cancer       Date:  2014-08       Impact factor: 60.716

View more
  15 in total

1.  Hsp90 inhibitors as senolytic drugs to extend healthy aging.

Authors:  Heike Fuhrmann-Stroissnigg; Laura J Niedernhofer; Paul D Robbins
Journal:  Cell Cycle       Date:  2018-07-23       Impact factor: 4.534

2.  [Mechanism of heat shock protein 90 for regulating 26S proteasome in hyperthermia].

Authors:  Qing-Rong Ma; Pei-Zhi Yu; Fan Zhang; Yu-Qi Li; Shu Yang; Xian-Yi Mo; Kai-Lan Mo; Ying Ding; Si-Ze Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

Review 3.  Regulatory Network of ARF in Cancer Development.

Authors:  Aram Ko; Su Yeon Han; Jaewhan Song
Journal:  Mol Cells       Date:  2018-04-18       Impact factor: 5.034

4.  Senescence Inducer Shikonin ROS-Dependently Suppressed Lung Cancer Progression.

Authors:  Hongming Zheng; Qiuju Huang; Suchao Huang; Xia Yang; Ting Zhu; Wensheng Wang; Haojia Wang; Shugui He; Liyan Ji; Ying Wang; Xiaoxiao Qi; Zhongqiu Liu; Linlin Lu
Journal:  Front Pharmacol       Date:  2018-05-23       Impact factor: 5.810

5.  Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells.

Authors:  Nerea Allende-Vega; Martin Villalba
Journal:  Sci Rep       Date:  2019-04-04       Impact factor: 4.379

Review 6.  Integrating cellular senescence with the concept of damage accumulation in aging: Relevance for clearance of senescent cells.

Authors:  Mikolaj Ogrodnik; Hanna Salmonowicz; Vadim N Gladyshev
Journal:  Aging Cell       Date:  2018-10-22       Impact factor: 9.304

Review 7.  Fibronectin in Cancer: Friend or Foe.

Authors:  Tsung-Cheng Lin; Cheng-Han Yang; Li-Hsin Cheng; Wen-Tsan Chang; Yuh-Rong Lin; Hung-Chi Cheng
Journal:  Cells       Date:  2019-12-20       Impact factor: 6.600

Review 8.  Chaperone-Mediated Autophagy in the Liver: Good or Bad?

Authors:  Srikanta Dash; Yucel Aydin; Krzysztof Moroz
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

Review 9.  Post-Translational Regulation of ARF: Perspective in Cancer.

Authors:  Jinho Seo; Daehyeon Seong; Seung Ri Lee; Doo-Byoung Oh; Jaewhan Song
Journal:  Biomolecules       Date:  2020-08-04

Review 10.  Heat Shock Protein 90 as Therapeutic Target for CVDs and Heart Ageing.

Authors:  Siarhei A Dabravolski; Vasily N Sukhorukov; Vladislav A Kalmykov; Nikolay A Orekhov; Andrey V Grechko; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.